Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 2
1(50.0%)
2Total
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06535113Recruiting

Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia

Role: collaborator

NCT02310061Not ApplicableCompleted

Lung Water by Ultrasound Guided Treatment in Hemodialysis Patients (The Lust Study).

Role: collaborator

NCT03923972Unknown

Exercise Training and Physical Rehabilitation in Patients With Chronic Kidney Disease in Europe - What is the Problem?

Role: collaborator

NCT04385043Phase 2Unknown

Hyperimmune Plasma in Patients With COVID-19 Severe Infection

Role: collaborator

All 4 trials loaded